Literature DB >> 27191048

Validation of HOMA-IR in a model of insulin-resistance induced by a high-fat diet in Wistar rats.

Luciana C Antunes1, Jessica L Elkfury2, Manoela N Jornada1, Kelly C Foletto1, Marcello C Bertoluci1.   

Abstract

Objective The present study aimed to validate homeostasis model assessment of insulin resistance (HOMA-IR) in relation to the insulin tolerance test (ITT) in a model of insulin-resistance in Wistar rats induced by a 19-week high-fat diet. Materials and methods A total of 30 male Wistar rats weighing 200-300 g were allocated into a high-fat diet group (HFD) (55% fat-enriched chow, ad lib, n = 15) and a standard-diet group (CD) standard chow, ad lib, n = 15), for 19 weeks. ITT was determined at baseline and in the 19th week. HOMA-IR was determined between the 18-19th week in three different days and the mean was considered for analysis. Area under the curve (AUC-ITT) of the blood glucose excursion along 120 minutes after intra-peritoneal insulin injection was determined and correlated with the corresponding fasting values for HOMA-IR. Results AUC-ITT and HOMA-IR were significantly greater after 19th week in HFD compared to CD (p < 0.001 for both). AUC-OGTT was also higher in HFD rats (p = 0.003). HOMA-IR was strongly correlated (Pearson's) with AUC-ITT r = 0.637; p < 0.0001. ROC curves of HOMA-IR and AUC-ITT showed similar sensitivity and specificity. Conclusion HOMA-IR is a valid measure to determine insulin-resistance in Wistar rats. Arch Endocrinol Metab. 2016;60(2):138-42.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27191048     DOI: 10.1590/2359-3997000000169

Source DB:  PubMed          Journal:  Arch Endocrinol Metab        ISSN: 2359-3997            Impact factor:   2.309


  45 in total

1.  Effects of metformin on prostatic tissue of rats with metabolic syndrome and benign prostatic hyperplasia.

Authors:  Congyun Xu; Yan Xu; Zhou Shen; Hangcheng Zhou; Jun Xiao; Tao Huang
Journal:  Int Urol Nephrol       Date:  2018-02-19       Impact factor: 2.370

2.  Omega 3 rich diet modulates energy metabolism via GPR120-Nrf2 crosstalk in a novel antioxidant mouse model.

Authors:  Deborah Amos; Carla Cook; Nalini Santanam
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2019-01-16       Impact factor: 4.698

Review 3.  Effects of Propolis Extract and Propolis-Derived Compounds on Obesity and Diabetes: Knowledge from Cellular and Animal Models.

Authors:  Hiroshi Kitamura
Journal:  Molecules       Date:  2019-12-01       Impact factor: 4.411

4.  PI3K/Akt pathway expression in children with different obesity degrees and its relationship with glucolipid metabolism and insulin resistance.

Authors:  Xiaoyan Su; Deming Gu; Li Xu; Zhenming Liang; Xuan Luo; Pu Yang; Jing Yang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

5.  A glucose-insulin-potassium solution improves glucose intake in hypoxic cardiomyocytes by a differential expression of glucose transporters in a metabolic syndrome model.

Authors:  R Carbo; E Rodriguez
Journal:  J Biosci       Date:  2019-03       Impact factor: 1.826

6.  Increased susceptibility to OVX-associated metabolic dysfunction in UCP1-null mice.

Authors:  Stephanie L Clookey; Rebecca J Welly; Terese M Zidon; MIchelle L Gastecki; Makenzie L Woodford; Zachary I Grunewald; Nathan C Winn; Dusti Eaton; Natalia G Karasseva; Harrold S Sacks; Jaume Padilla; Victoria Vieira-Potter
Journal:  J Endocrinol       Date:  2018-08-08       Impact factor: 4.286

7.  Endurance running exercise is an effective alternative to estradiol replacement for restoring hyperglycemia through TBC1D1/GLUT4 pathway in skeletal muscle of ovariectomized rats.

Authors:  Mizuho Kawakami; Naoko Yokota-Nakagi; Akira Takamata; Keiko Morimoto
Journal:  J Physiol Sci       Date:  2019-11-28       Impact factor: 2.781

8.  Liver inflammation at the time of spinal cord injury enhances intraspinal pathology, liver injury, metabolic syndrome and locomotor deficits.

Authors:  Matthew T Goodus; Kaitlin E Carson; Andrew D Sauerbeck; Priyankar Dey; Anthony N Alfredo; Phillip G Popovich; Richard S Bruno; Dana M McTigue
Journal:  Exp Neurol       Date:  2021-04-30       Impact factor: 5.330

9.  Multitarget molecule, PTUPB, to treat diabetic nephropathy in rats.

Authors:  Md Abdul Hye Khan; Sung Hee Hwang; Scott D Barnett; Anna Stavniichuk; Wojciech K Jankiewicz; Bruce D Hammock; John D Imig
Journal:  Br J Pharmacol       Date:  2021-08-12       Impact factor: 8.739

10.  Impact of combined therapy of mesenchymal stem cells and sitagliptin on a metabolic syndrome rat model.

Authors:  Yossra Ahmed; Zeinab Y Ali; Mona A Mohamed; Laila A Rashed; Ehsan K Mohamed
Journal:  J Diabetes Metab Disord       Date:  2021-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.